The 50-mg dose of the investigational drug brilaroxazine significantly reduced symptoms of schizophrenia in adults within 4 weeks in the phase III RECOVER trial, developer Reviva Pharmaceuticals announced.
Severe mental illness was linked with a 50% higher risk of death following COVID infection. (British Journal of Psychiatry)
A simple blood test may bolster the differential diagnosis of mood disorders, like bipolar disorder versus major depressive disorder. (JAMA Psychiatry)
The proportion of children and adolescents who received mental health counseling or therapy increased from 10% in 2019 to 13.8% in 2022, CDC data showed.
Exactly how do psychedelics work as psychiatric therapeutics? (Nature)
Among schoolkids in the same grade diagnosed with ADHD, those of younger age were just as likely to retain their diagnosis over time as their older classmates. (Lancet Psychiatry)
Twice as many parents of kids ages 9 to 15 reported concerns about internet addiction compared with substance addiction. (JAMA Network Open)
Former President Donald Trump called for the return of “mental institutions” as a way to reduce homelessness, if elected to a second term. (Axios)
More mental health professionals are coming to Medicare. (Washington Post)